The aim of this study was to investigate the potential of combined textural feature analysis of contrast-enhanced MRI (CE-MRI) and static O-(2-[ 18 F]fluoroethyl)-L-tyrosine (FET) PET for the differentiation between local recurrent brain metastasis and radiation injury since CE-MRI often remains inconclusive.
A C C E P T E D M A N U S C R I P T INTRODUCTION
Over recent years, the treatment of brain metastasis using radiotherapy has evolved substantially. Treatment options include local postoperative external fractionated radiotherapy, stereotactic radiosurgery, interstitial brachytherapy, and whole-brain radiotherapy [1] . All these methods, applied solely or in combination, may lead to local radiation doses that exceed tolerance levels of normal brain tissue and may accordingly result in a radiation injury. The frequency of which radiation injury occurs depends on the applied method of radiotherapy. After stereotactic radiosurgery, radiation injuries occur in 5-34% of cases [2] [3] [4] [5] [6] . In contrast, a radiation injury is uncommon after fractionated (local or whole-brain) radiotherapy alone (incidence, 0-5%) [7-10] and is also rare after low-dose brachytherapy [11] . Typically, after radiosurgery, radiation injuries develop within a median time range of 7-11 months [2] [3] [4] [5] [6] . Moreover, in a subgroup of long-term survivors radiation injuries after stereotactic radiosurgery have also been reported after more than 5 years (median time, 33 months) [12] . Unfortunately, neurological signs and symptoms caused by both recurrent brain metastasis and radiation injury are indistinguishable and hence often impose severe clinical problems during the follow-up [13] .
Contrast-enhanced MRI (CE-MRI) is routinely used in clinical practice for the followup of patients with previously irradiated brain metastases. However, recurrent brain metastases cannot easily be differentiated from radiation injury using conventional MRI [14] . More recently, the differentiation between radiation injury and recurrence of brain metastasis has been markedly improved by imaging parameters derived from static and dynamic amino acid PET scans, suggesting that a diagnostic accuracy in the range between 80-90% can be obtained [15] [16] [17] [18] [19] [20] [21] . However, dynamic FET PET
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5 scans require a more costly and time-consuming acquisition, data reconstruction and analysis and, thus, are not yet implemented in clinical routine.
Textural feature analysis of inconclusive lesions on PET [22] and MR images [23] [24] [25] [26] is another promising approach. It is based on the assumption that the microstructure of a process depends on the underlying pathology and is reflected in subtle differences in the radiological image that cannot be detected by means of human perception but can be made accessible by high-dimensional quantitative image analysis often referred to as "radiomics". It seems likely that such an approach could be improved by combining PET and MR image analysis, which may derive special features based upon complementary tissue properties.
Here, we report for the first time the usefulness of combined PET/MRI radiomics analysis using CE-MRI and FET PET scans in patients with brain metastases.
Following simple normalization, reslicing, and resampling procedures of already obtained neuroimages, we demonstrate that freely available radiomics image analysis tools can be used to differentiate brain metastasis recurrence from radiation injury with a high accuracy, particularly when the information from both CE-MRI and FET PET is combined.
PATIENTS AND METHODS

Patients
We previously evaluated in 62 patients after radiotherapy the diagnostic accuracy of dynamic FET PET for the differentiation of brain metastasis recurrence from radiation injury [15] . In order to perform a PET/MRI textural feature analysis, FET PET data and CE-MRI of these patients were re-evaluated. Of these patients, 52 patients (mean age, 55 ± 10 years (y); range 17-75 y; 39 women and 13 men) were eligible for data evaluation. Ten patients had to be excluded because they were investigated on a different PET scanner.
In brief, these patients with brain metastasis, each having at least one newly diagnosed or progressive contrast-enhancing lesion on cerebral MRI, were referred to our center for the differentiation between brain metastasis recurrence and radiation injury. The median time interval between MRI and PET acquisition was 15 days. Prior to the suspicious CE-MRI, brain metastases had been treated with radiotherapy, i.e., stereotactic radiosurgery, whole-brain radiotherapy, interstitial brachytherapy, external fractionated radiotherapy, or combinations thereof. In detail, forty-five patients (87%) received stereotactic radiosurgery, five patients (10%) had fractionated (local or whole-brain) radiotherapy alone, and two patients (4%) were treated with low-dose brachytherapy. 
ACCEPTED MANUSCRIPT
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The definite diagnosis (brain metastasis recurrence or radiation injury) was based upon histopathology in 19 patients (37%) or follow-up including the clinical course and serial MR imaging in 33 patients (63%). Recurrent disease was anticipated if a new contrast-enhancing lesion appeared at exactly the same site as the previously treated metastasis after initial complete response or if the treated metastasis showed progression in size during follow-up according to Response Assessment in Neuro-Oncology (RANO) criteria for brain metastasis [27] (increase of > 20% of the pretreated volume on CE-MRI) and new neurological deficits or the exacerbation of existing neurological symptoms, prompting a change in treatment.
Radiation injuries in the tissue were assumed if (i) the lesions showed spontaneous shrinkage, remained stable in size, or showed a temporally increase of size followed by a spontaneous shrinkage to or below the initial size on CE-MRI during follow-up (median follow-up, 15 mo; range, 3-63 mo); (ii) neurological deficits remained unchanged; (iii) and no new neurological symptoms occurred. In four cases rated as radiation injury, the follow-up time was shorter than 6 months so that stable disease cannot be completely ruled out. In these cases, the classification as radiation injury was additionally based on a negative FET PET scan.
More details about the patient cohort and the clinical follow-up are provided in Supplementary Table 1 .
MR Imaging
Standard MR imaging procedures comprised T1-weighted contrast-enhanced axial series, T2-weighted, and fluid attenuated inversion recovery (FLAIR) sequences. As
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9 described previously, only the axial T1-weighted contrast-enhanced sequences were used for data evaluation [25] .
FET PET Imaging
The amino acid FET was produced via nucleophilic 18 F-fluorination with a radiochemical purity greater than 98%, a specific radioactivity greater than 200
GBq/µmol, and a radiochemical yield of about 60%, as previously described [28] . All patients fasted for at least 4 h before the PET measurement according to the German guidelines for brain tumor imaging using labelled amino acid analogues [29] . All 
Image pre-processing and VOI definition
Using the software PMOD (version 3.505, PMOD Technologies Ltd., Zurich, Switzerland), the CE-MR images were resliced to a resolution of 1 x 1 x 1 mm. A B0field correction was not applied. In patients with multiple lesions, only the lesion with the largest volume was used for textural feature analysis, because this method provides reliable results by selecting regions that contain a sufficient number of 
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The FET PET VOIs were determined by a 3D auto-contouring process using a TBR of 1.6 or more. This threshold is based on a biopsy-controlled study in which this value separated best between vital tumor and healthy brain parenchyma in FET PET [34] . In cases of non-enhancing PET lesions (n=7), the MR VOIs were registered to the PET images and used for further analysis. No additional filtering was applied for the PET images.
Radiomic feature extraction
Textural feature analysis was performed using the freely available software LIFEx (Version 3.3, lifexsoft.org) [35] . Forty-two features were calculated for each VOI including five statistical indices (minimum, mean, maximum, standard deviation of grey levels from the histogram, and VOI volume), 4 first-order histogram features, 31
second-order features from the grey level co-occurrence matrix (GLCM), neighborhood grey-level different matrix (NGLDM), grey-level run length matrix (GLRLM), and grey-level zone length matrix (GLZLM), and two shape indices (sphericity and compacity). A detailed description of each textural parameter is available in the technical appendix of the LIFEx software [30] . For the second-order features in MRI and FET PET, intensity resampling was performed using the mean and three standard deviations of the grey levels in the VOI as lower and upper limits and rescaling to 64 bins. In 6 cases (Patient number 28, 30, 35, 38, 48, 49) , the PET VOIs contained less than 100 voxels and were therefore excluded from the analysis ( Supplementary Table 1 ) [30] .
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Radiomic feature selection
Calculating large numbers of features on a limited number of patients potentially includes substantial redundancy and might lead to overfitting and misclassification in modelling. Therefore, feature selection for identification of a useful, restricted subset of features for classification of radiation injury from recurrent brain metastasis was performed. First, the Mann-Whitney-U test was used to identify features from MRI and FET PET separately as well as from the combination of both modalities that encode statistically significant (p < 0.05) intergroup differences. Second, the maximum number of features allowed in each single modality model and the combined FET PET/MRI model was restricted to five features according to published recommendations [36, 37] .
Model generation
The best performing generalized linear model (logistic regression) was generated using the 'bestglm' R-package (Version 3.4.1, R Studio, Inc., Boston, MA, USA) by applying the Akaike Information Criterion [38] . The algorithm was parameterized to select the best model that contained a maximum of five variables according to feature selection. Model generation was applied to the features from the two imaging modalities separately as well as to the combined feature set.
Model validation
The validity of the models for differentiation of recurrent metastasis from radiation injury was assessed using cross-validation (MATLAB, R2017b. Mathworks, Inc., MA, USA). Three commonly used cross-validation methods (leave-one-out, 5-fold, and 10-fold cross-validation) were applied to the models based on the two imaging modalities and the combined model. Additionally, sensitivity, specificity, accuracy, and receiver operating characteristic curves (ROC) were calculated for each modality and the combined feature sets.
RESULTS
Recurrent metastatic tumor was found in 21 (40%) and radiation injury in 31 (60%) of 52 patients.
Of the 42 analyzed MRI features, 22 features were significantly more frequent in patients with brain metastasis recurrence than in patients with radiation injury (p < 0.05; 13 features from the unfiltered images, 4 features from the LOG filtered and 5
features from the wavelet filtered images) ( Figure 2 , Supplementary Tables 2 and 3 ).
The best logistic regression five-variable model yielded a sensitivity of 67%, a specificity of 90%, and an accuracy of 81% ( Table 2 ). The overall accuracy of the model validation was 71% for leave-one-out cross-validation (LOOCV), 77% for 5fold cross-validation (CV) and 74% for 10-fold cross-validation. Further details on the model performance and the validation are provided in Table 2 . Similarly, 23 FET PET textural feature values were significantly more frequent in patients with brain metastasis recurrence than in patients with radiation injury (p < 0.05 for 23 features, p < 0.01 for 19 features, p < 0.005 for 8 features; Figure 2 and Supplementary Table 4 ). The best logistic regression model including 5 variables yielded a sensitivity to detect a recurrence of 88%, a specificity of 75%, and a diagnostic accuracy of 83% ( Table 2 ). The overall accuracy of the model validation was 72% for leave-one-out cross-validation (LOOCV), 74% for 5-fold cross-validation (CV) and 76% for 10-fold cross-validation. Further details on the model performance and the validation are provided in Table 2 . Representative MRI and FET PET images are shown in Figure 1 . transformed MR images and one FET PET feature and resulted in a sensitivity of 85%, a specificity of 96%, and an accuracy of 89% ( Figure 2 and Table 2 ). The overall accuracy of the model validation was 83% for leave-one-out cross-validation (LOOCV), 80% for 5-fold cross-validation (CV) and 83% for 10-fold cross-validation.
Further details on the model performance and the validation are provided in Table 2 .
DISCUSSION
In the present study, we evaluated the ability of both MRI and FET PET radiomic features for the differentiation between brain metastasis recurrence and radiation injury in previously irradiated brain metastases of patients who presented with inconclusive MRI findings. The main finding of our study is that textural features derived from CE-MRI and static FET PET increase the diagnostic accuracy for the correct differentiation of radiation injury from brain metastasis recurrence to almost 90%, compared to each modality alone (82% for CE-MRI, and 83% for FET PET) without the need for a more costly and time-consuming dynamic FET PET acquisition, which is necessary for the evaluation of kinetic PET parameters.
Importantly, our analysis was based on standard CE-MRI and static FET PET images that had already been acquired during the routine follow-up of the patients. Thus, no additional measurements or image acquisitions beyond clinical routine were necessary, which speaks for the clinical feasibility of this approach. Although no independent validation cohort was available, the model was validated using crossvalidation with different numbers of subsamples, which is a common procedure for model validation with a limited number of samples. Here, the combined model proved valid in the cross-validation yielding high diagnostic accuracies above 80%.
Over the past years, several studies have demonstrated that amino acid PET alone is a potent imaging method for the identification of treatment-related changes such as pseudoprogression [39] [40] [41] [42] or radiation injury [15, 17, 22] in patients with glioma and brain metastasis. For the differentiation of radiation injury from brain metastasis recurrence, the diagnostic accuracy of static (i.e., tumor/brain ratios) and dynamic FET PET parameters (i.e., time-to-peak values and the slope of time-activity curves)
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20 has been evaluated in a pilot study by Galldiks and co-workers [17] . By combining these PET parameters, diagnostic accuracy in the range of 80-90% was obtained.
Subsequently, these results have been confirmed by Ceccon et al. in a larger group of patients [15] . Recently, Romagna and colleagues reported a similar diagnostic accuracy [43] . However, in all these studies, dynamic FET PET parameters that weighted images compared to a well-delineated margin of contrast enhancement on T1-weighted images ("T1/T2-mismatch") was significantly associated with a higher rate of radiation injury after radiosurgery (sensitivity, 83%; specificity, 91%).
21 However, these approaches were only qualitative, potentially resulting in a high interobserver variability.
Recently, more advanced MRI-based approaches using quantitative image analysis and machine learning methods have been applied for the differentiation of radiation injury from recurrent brain metastasis. To the best of our knowledge, this is the first study that combines MR and FET PET radiomics. As CE-MRI and FET PET decode different (patho-)physiological mechanisms that complement each other and may be accessible through textural feature analysis, a combined, multimodal predictor has the potential to outperform single modality models. This assumption is clearly supported by our findings where the combination of both modalities yielded the highest diagnostic performance compared to the single modality models.
As depicted in Figure 2 , many of the textural features that discriminated best between radiation injury and brain metastasis recurrence were found on both MR (unfiltered and filtered) and FET PET images. This is an interesting observation because the underlying mechanisms that determine signal intensities are thought to differ substantially. While the contrast enhancement on MRI represents disruption of the blood-brain barrier (BBB), the increased FET uptake depicted by PET is caused by an overexpression of large neutral amino acid transporters (LAT) leading to an increased accumulation of FET in brain tumors which is not influenced by the BBB permeability [49, 50] . The observation that the same textural parameters in MRI and FET PET have the highest discriminatory power suggest that patterns of altered amino acid transport and BBB disruption in recurrent metastasis and radionecrosis are altered in the same direction and that there is a fundamental relationship between the physiologically completely different parameters.
Many approaches predominantly in the field of MRI radiomics often use specialized self-developed software that is poorly validated and limits the applicability and accessibility for other groups. Furthermore, high-performance computers are frequently needed for the analysis. In contrast, the software used in the present study is well validated, freely available, and the analysis can be easily performed within a few minutes using routinely acquired multimodal images on a standard computer. In summary, the analysis employed here is readily applicable, easy to implement, and cost-effective.
With regard to the implementation of radiomics into clinical routine, our results warrant further investigation. This should also include a better understanding of the link of specific radiomic features with the underlying pathophysiology, given that it is difficult to translate directly a mathematical description of a radiomic or textural feature into a visual impression or physiological meaning [51] . In our analysis, patients with brain metastasis recurrence showed a more heterogeneous contrastenhancement and FET uptake (Figure 1) . Additionally, the shape of the recurrent metastases in both MRI and PET was less spherical compared to radiation injuries ( Figure 1 ). In the calculated models, particularly features reflecting non-uniformity were dominant and hence achieved higher values in patients with brain metastasis recurrence. Accordingly, findings in recurrent brain metastasis seem to be more heterogeneous than in radiation injuries [52, 53] .
CONCLUSIONS
In conclusion, our results suggest that combined FET PET and MRI radiomics as assessed by textural feature analysis encode more information than either modality alone and is useful for the differentiation between radiation injury and brain metastasis recurrence. Our results warrant both replication and further investigation into the pathophysiology underlying radiomic features.
A C C E P T E D M A N U S C R I P T
25
DISCLOSURE
This study was partly supported by the Wilhelm Sander-Stiftung, Munich, Germany (No. 2016.069.1 to N.G.). All other authors report no conflicts of interest. However, this differentiation based on contrast-enhanced conventional MRI is often inconclusive. Since radiomics and hybrid amino acid PET/MR imaging are increasingly gaining attention in Neuro-Oncology, we evaluated the potential of combined static FET PET/MRI textural features for the differentiation of recurrent brain metastasis from radiation injury. Here, we report for the first time the usefulness of combined PET/MRI radiomics analy sis using contrast-enhanced MRI and FET PET scans in patients with brain metastases. Following simple normalization, reslicing, and resampling procedures of already obtained neuroimages, we demonstrate that freely available radiomics image analysis tools can be used to differentiate brai n metastasis recurrence from radiation injury with a high diagnostic accuracy of approximately 90%, particularly when the information from both contrast -enhanced MRI and FET PET is combined.
